Keyphrases
Anti-vascular Endothelial Growth Factor (anti-VEGF)
10%
Anti-VEGF Therapy
18%
Best-corrected Visual Acuity
35%
Cataract
16%
Central Macular Thickness
20%
Choroidal Neovascular Membrane
11%
Corticosteroids
19%
Cystoid Macular Edema
25%
Dexamethasone Implant
20%
Diabetic Macular Edema
40%
Disease Control
10%
Etiology
11%
Eye Drops
10%
Functional Outcome
15%
Glaucoma
18%
Interdigitation Zone
10%
Intraocular Pressure
21%
Intravitreal Injection
24%
Logarithm of the Minimum Angle of Resolution
11%
Long-term Clinical Outcome
10%
Macular Edema
40%
Non-infectious Uveitis
30%
Ocular Complications
15%
Ocular Inflammation
30%
Ocular Treatment
10%
Online Classifier
10%
Pediatric Uveitis
10%
Pseudophakic Macular Edema
12%
Raised Intraocular Pressure
22%
Response Predictors
22%
Retinal Layer Thickness
20%
Retinal Layers
13%
Retinal Nerve Fiber Layer
21%
Retinal Nerve Fiber Layer Thickness (RNFLT)
12%
Retinal Thickness
20%
Spectral Domain Optical Coherence Tomography (SD-OCT)
11%
Steroid Treatment
10%
Systemic Immunosuppression
11%
Tolerability
12%
Treatment Outcome
20%
Treatment Trials
10%
Treatment-naïve Patients
10%
Uveitic
11%
Uveitis
100%
Vision Loss
30%
Visual Acuity
30%
Visual Function
15%
Visual Loss
11%
Visual Outcome
29%
Vitreous Haze
11%
Medicine and Dentistry
Age Related Macular Degeneration
11%
Agents Acting on the Eye
10%
Antibiotics
10%
Antiinfective Agent
11%
Antirheumatic Agent
10%
Avacincaptad Pegol
10%
Best Corrected Visual Acuity
30%
Bevacizumab
11%
Biological Marker
10%
Cat-Scratch Disease
10%
Cataract
8%
Choroidal Neovascular Membrane
11%
Choroidal Neovascularization
10%
Choroiditis
10%
Cluster Analysis
10%
Dexamethasone
20%
Diabetes Mellitus
7%
Diabetic Macular Edema
40%
Diseases
30%
Endophthalmitis
12%
Epiretinal Membrane
10%
Eye Disease
12%
Geographic Atrophy
10%
Glaucoma
14%
Hemodialysis
10%
Immunosuppressive Treatment
11%
Implant
10%
Intermediate Uveitis
10%
Intraocular Pressure
28%
Intravitreal Administration
13%
Macular Edema
43%
Optical Coherence Tomography
20%
Patient Referral
7%
Pediatrics
10%
Randomized Controlled Trial
10%
Retina Macula Cystoid Edema
21%
Retinal Disease
10%
Retinal Nerve Fiber Layer
15%
Retinal Vasculitis
10%
Retrospective Study
15%
Rheumatic Disease
10%
Spectral Domain Optical Coherence Tomography
11%
Steroid Treatment
10%
Subconjunctival Hemorrhage
10%
Supplementation
12%
Uveitis
80%
Vasculitis
8%
Vasculotropin
24%
Visual Acuity
37%
Visual Impairment
37%
Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
11%
Antibiotics
7%
Antiinfective Agent
11%
Avacincaptad Pegol
10%
Bevacizumab
11%
Biological Marker
10%
Bleeding
16%
Cat Scratch Disease
10%
Cataract
15%
Dexamethasone
20%
Diabetes Mellitus
10%
Diabetic Macular Edema
40%
Diabetic Retinopathy
5%
Diseases
22%
Edema
5%
Eye Disease
12%
Geographic Atrophy
10%
Hemodialysis
10%
Implant
9%
Inflammation
10%
Injection Pain
10%
Intermediate Uveitis
10%
Intravitreal Administration
25%
Macular Edema
41%
Methotrexate
10%
Randomized Controlled Trial
10%
Remission
10%
Retina Macula Cystoid Edema
26%
Retrospective Study
15%
Scar Formation
5%
Tolerability
12%
Uveitis
57%
Vasculotropin
30%
Visual Impairment
27%
